HOME
HK STOCK
ALL
Announcement
IPOs
Research
Market
Company
CHINA STOCK
ALL
Announcement
IPOs
Research
Market
Company
US STOCK
ALL
Financial Report
New Share
Market
Research
Company
RECOMMENDATIONS
ALL
World News
Hong Kong & MaCao
China News
General News
HK STOCK
ALL
Announcement
IPOs
Research
Market
Company
CHINA STOCK
ALL
Announcement
IPOs
Research
Market
Company
US STOCK
ALL
Financial Report
New Share
Market
Research
Company
RECOMMENDATIONS
ALL
World News
Hong Kong & MaCao
China News
General News
HOME
HK STOCK
ALL
Announcement
IPOs
Research
Market
Company
CHINA STOCK
ALL
Announcement
IPOs
Research
Market
Company
US STOCK
ALL
Financial Report
New Share
Market
Research
Company
RECOMMENDATIONS
ALL
World News
Hong Kong & MaCao
China News
General News
Search for topics & keywords
Search
VIVA BIOTECH (01873) spent HKD 907,600 on November 12th to buy back 1,000,500 shares.
12/11/2024
GMT Eight
VIVA BIOTECH (01873) announced on November 12, 2024, that the company has spent HK$907,600 to repurchase 1,005,000 shares.
Barclays: Slower pace of Federal Reserve interest rate cuts may put greater pressure on Asian currencies.
SUN.KING TECH (00580) spent 108,300 Hong Kong dollars to repurchase 90,000 shares on November 12th.
RECOMMEND
ELIFE HLDGS(00223): Shousheng Capital Group Limited has been appointed as the independent financial advisor.
19 min ago
The stock price has doubled in half a year, with the commercialization of ASCENTAGE-B (06855) APG-2575 imminent, and an expected increase in valuation.
20 min ago
BOSS ZHIPIN-W (02076) plans to purchase a total of 372,900 shares of Class A common stock after the initial public offering.
37 min ago
©️2013 - 2024 GMT EIGHT Holdings. All Rights Reserved.
Contact: contact@gmteight.com